ORAMED PHARMACEUTICALS INC. - 17 Feb 2026 SCHEDULE 13D/A Report for Nano Dimension Ltd. Ordinary Shares, par value NIS 5.00 per share (NNDM)

Filing Manager: ORAMED PHARMACEUTICALS INC.
Reporting Manager: Oramed Pharmaceuticals Inc.
Security: Nano Dimension Ltd. Ordinary Shares, par value NIS 5.00 per share
Symbol: NNDM
Shares outstanding: 210,424,750 shares
Disclosed Ownership: 10,942,087 shares
Ownership: 5.2%
Form type: SCHEDULE 13D/A
Filing time: 19 Feb 2026, 21:50:01 UTC
Date of event: 17 Feb 2026
Previous filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Oramed Pharmaceuticals Inc.	5.2%	10,942,087	0	10,942,087	/s/ Avraham Gabay	Avraham Gabay, Chief Financial Officer	0001176309